Author/Authors :
Farazmand, Borna Department of Radiation Oncology - Cancer Institute - Tehran University of Medical Sciences, Tehran , Yamrali, Maisa Department of Radiation Oncology - Cancer Institute - Tehran University of Medical Sciences, Tehran , Ghalehtaki, Reza Department of Radiation Oncology - Cancer Institute - Tehran University of Medical Sciences, Tehran , Habibi, Mehran Department of Surgery - Johns Hopkins Bayview Campus - Baltimore, USA
Abstract :
During recent decades, our understanding of the
characteristics of breast cancer has improved,
leading to improvements in individualized treatment
methods historically, neoadjuvant chemotherapy
(NAC) was limited to inoperable breast cancer , 1
however, according to the results of several studies
in some centers around the world this method has
become the routine practice in almost all stages of
breast cancer (except for the very early ones).
Keywords :
NAC , Optimal , Chemotherapy , EORTC
